Oscar Health, Inc. Hits New 52-Week Low at $11.05

Oscar Health, Inc., a small-cap player in the healthcare services industry, has reached a new 52-week low of USD 11.05 as of March 27, 2026. This significant decline marks a stark contrast to its 52-week high of USD 23.74, reflecting a challenging year for the company with a performance drop of 45.69%. The company's market capitalization stands at approximately USD 3,958 million, and it currently operates without a dividend yield. Financial metrics indicate a difficult landscape, with a return on equity of -45.30% and a debt-to-equity ratio of -3.64. The operating profit for the most recent quarter was reported at a loss of USD 230.48 million, contributing to an operating profit margin of -8.05%. Oscar Health's performance has been under pressure, particularly following a series of negative results over the past nine quarters. The stock's current trajectory highlights the challenges faced within the healthcare sector, as it navigates through a period of significant financial strain.